Simple blood test may replace biopsies for kidney rejection detection
NCT ID NCT07275541
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is looking at whether changes in platelet function can signal acute rejection in kidney transplant recipients. Researchers will measure platelet activity before and after transplant, and at times of suspected rejection. The goal is to develop a non-invasive blood test that could reduce the need for invasive biopsies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a non-invasive blood test to detect kidney transplant rejection, reducing the need for biopsies.
- What could go wrong
- This is a small, early observational study. The platelet test may not reliably distinguish rejection from other causes of kidney dysfunction.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANT REJECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Transplant-Nephrology Department, University Hospital Martin
RECRUITINGMartin, 03601, Slovakia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can your gut bacteria change how transplant drugs work?
- Your gut bacteria might predict transplant rejection
- Engineered immune cells aim to trick the body into accepting a new kidney
- Can white ginseng boost blood flow? new trial investigates
- New imaging method could speed up diagnosis of blood clotting disorders
- Massive data dive aims to outsmart kidney transplant rejection